Scinovex
review Open AccessTop 1% cited

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

The British Journal of Psychiatry · 2001 · Vol. 178(3) · pp. 234–241

Abstract

Remission rates were significantly higher with venlafaxine than with an SSRI.

Treatment of Major DepressionNeurotransmitter Receptor Influence on BehaviorAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesVenlafaxineParoxetineFluvoxamineFluoxetineVenlafaxine HydrochlorideReuptake inhibitorPlaceboAntidepressantInternal medicineHamilton Rating Scale for Depression

MeSH terms

Venlafaxine HydrochlorideAdultCyclohexanolsDepressive DisorderDouble-Blind MethodFemaleHumansMaleRandomized Controlled Trials as TopicTreatment OutcomeSelective Serotonin Reuptake InhibitorsAntidepressive Agents, Second-Generation
Citations
805
FWCI
41.44
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
References
A Molecular and Cellular Theory of Depression
Archives of General Psychiatry · 1997 · 2,113 citations
A RATING SCALE FOR DEPRESSION
Journal of Neurology Neurosurgery & Psychiatry · 1960 · 32,326 citations
A New Depression Scale Designed to be Sensitive to Change
The British Journal of Psychiatry · 1979 · 13,782 citations
Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Journal of Pharmacology and Experimental Therapeutics · 1997 · 670 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors · Scinovex